Rate My Professor Nora Caberoy

In Alzheimer’s research, she engineers novel hybrid proteins that bind oligomeric and fibrillar amyloid beta, sequestering it and directing phagocytic clearance via non-inflammatory pathways to reduce neuroinflammation. Caberoy received the prestigious National Institutes of Health/National Eye Institute Pathway to Independence Career Development Award. Her key publications include "Secretogranin III as a disease-associated ligand for antiangiogenic therapy of diabetic retinopathy" (2017), "Lyar Is a New Ligand for Retinal Pigment Epithelial Phagocytosis" (2015), "ABCF1 extrinsically regulates retinal pigment epithelial cell phagocytosis" (2015), "Reticulocalbin-1 Facilitates Microglial Phagocytosis" (2015), "Hepatoma-Derived Growth Factor-Related Protein-3 Is a Novel Angiogenic Factor" (2015), "Tubby Regulates Microglial Phagocytosis through MerTK" (2012), and "Galectin-3 is a new MerTK-specific eat-me signal" (2012). She has submitted a patent application for a chimeric protein-based method to clear amyloid beta. With 1,112 citations, Caberoy's contributions significantly advance retinal biology and neurodegenerative disease therapies.